Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bornova
Clinical trial register · Turkey

Clinical Trials in Bornova, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC20 Eli Lilly and Company9 Regeneron Pharmaceuticals5 Azafaros B.V.4 Akero Therapeutics, Inc3
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in Bornova

77 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Not yet open
Azafaros B.V.
Phase 2
20
Bornova, Yenimahalle
2026-09-28
Recruiting
Biocon Biologics UK PLC
Phase 1
120
Ankara, Bornova, Konak
2026-09-09
Not yet open
Genetic Variants in Idiopathic Premature Ovarian Insufficiency
NCT07587853Premature Ovarian Insufficiency
Abdurrahman Hamdi İnan
Observational
100
Bornova
2026-06-10
Recruiting
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Observational
52
Bornova
2026-04-30
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
DrugZotemtegrast
Eli Lilly and Company
Phase 2
1,431
Adana, Ankara, Antalya, Bornova, Hatay, Istanbul, İzmit, Mersin
2026-03-26
Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
NCT07169851Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Eli Lilly and Company
Phase 2
204
Adana, Ankara, Antalya, Bornova, Edirne, Gaziantep, Pendik, Sakarya
2025-11-28
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
NCT06960213Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2
ADARx Pharmaceuticals, Inc.
Phase 3
90
Ankara, Bornova, Istanbul, Kayseri
2025-08-28
Recruiting
Azafaros B.V.
Phase 3
147
Adana, Çankaya, Bornova
2025-06-30
Active, closed
Azafaros B.V.
Phase 3
75
Adana, Çankaya, Bornova
2025-06-30
Recruiting
Azafaros B.V.
Phase 3
72
Adana, Çankaya, Bornova
2025-06-30
Recruiting
Regeneron Pharmaceuticals
Phase 2
297
Seyhan, Altındağ, Istanbul, Bornova, Gaziantep, Adana, Ankara, Izmir
2025-05-28
Recruiting
Pfizer
Phase 1
15
Bornova, Fatih
2025-05-13
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Bornova, Adana, Ankara, Istanbul, Sakarya, Samsun
2025-03-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
67
Bornova, Ankara, Istanbul
2024-11-21
Active, closed
A Study of Mosliciguat in PH-ILD
NCT06635850Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases
DrugMosliciguat
Pulmovant, Inc.
Phase 2
135
Pendik, Bornova
2024-10-29
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
DrugEfruxifermin
Akero Therapeutics, Inc
Phase 3
2,150
Bornova, Ankara, Bursa, Rize
2024-09-04
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
NCT06395103B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma
DrugZilovertamab vedotin
Merck Sharp & Dohme LLC
Phase 1/2
90
Bornova, Ankara
2024-08-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Bornova, Ankara, Eskişehir, Kayseri, Kocaeli
2024-08-05
Active, closed
Regeneron Pharmaceuticals
Phase 2
195
Adana, Bornova, Kocaeli, Sakarya, Konya, Kurupelit, Gaziantep, Ankara
2024-07-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Bornova, Ankara, Antalya, Edirne, Istanbul, Kocaeli, Samsun
2024-07-16
Recruiting
Immunocore Ltd
Phase 3
680
Yüreğir, Çankaya, Kepez, Antalya, Şehitkamil, Bahçelievler, Bornova, Cordaleo
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Bornova, Ankara, Antalya, Eskişehir, Istanbul, Kocaeli
2024-06-05
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
89bio, Inc.
Phase 3
762
Bornova, Merkez, Ankara, Fatih, Istanbul, Izmir, Sarıçam, Umraniye
2024-05-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Balçova, Bornova, Adana, Ankara, Istanbul, Sakarya
2024-05-24
By invitation
Travere Therapeutics, Inc.
Phase 3
100
Ankara, Bornova, Istanbul
2024-04-30
Active, closed
Eli Lilly and Company
Phase 3
10,000
Afyonkarahisar, Ankara, Antalya, Bornova, Çorum, Edirne, Eskişehir, Gaziantep
2024-04-30
Recruiting
CSL Behring
Phase 2/3
3,110
Ankara, Antalya, Atakum, Bakırköy, Bornova, Edirne, Gaziantep, İzmit
2024-04-27
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
DrugPirfenidone
Avalyn Pharma Inc.
Phase 2
375
Bornova, Adana, Ankara
2024-04-03
Recruiting
Italfarmaco
Phase 3
220
Bahçelievler, Bornova, Mezitli, Altınova
2024-03-26
Recruiting
CSL Behring
Phase 3
35
Bornova, Gaziantep, Seyhan
2024-01-30
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Bornova, Ankara, Antalya, Edirne, Istanbul, Kocaeli, Mersin, Samsun
2023-12-31
Recruiting
Travere Therapeutics, Inc.
Phase 3
70
Ankara, Bornova, Istanbul
2023-12-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Stanbul, Bornova, Talas, Adana, Ankara, Denizli, Istanbul, Samsun
2023-12-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
Stanbul, Bornova, Ankara, Istanbul
2023-12-06
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
Yenimahalle, Bornova, Bursa, Rize
2023-12-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
556
Stanbul, Bornova, Adana, Ankara, Istanbul
2023-11-12
Active, closed
Akero Therapeutics, Inc
Phase 3
700
Yenimahalle, Bornova, Bursa, Rize
2023-11-10
Recruiting
LeonaBio
Phase 3
600
Çankaya, Çapa, Kadiköy, Bornova, Konak, İzmit, Ankara, Bursa
2023-10-31
Active, closed
Summit Therapeutics
Phase 3
1,600
Sur, Bornova, İzmit, Meram, Ankara, Gaziantep, Istanbul, Izmir
2023-10-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Altindağ, Bornova, Cordaleo, Melikgazi, Adana, Ankara, Antalya, Çanakkale
2023-10-09
Recruiting
Acrotech Biopharma Inc.
Phase 3
504
Altındağ, Çankaya, Yenimahalle, Şişli, Adana, Bornova
2023-10-04
Active, closed
Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder
NCT05977634Overactive Bladder, Overactive Bladder Syndrome, Overactive Detrusor
Ege University
Not applicable
26
Bornova
2023-09-30
Recruiting
Merck Sharp & Dohme LLC
Phase 3
735
Bornova, Tekirdağ, Ankara, Istanbul
2023-08-08
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Bornova, İzmit, Antalya, Kayseri
2023-07-06
Active, closed
Regeneron Pharmaceuticals
Phase 2/3
149
Adana, Altındağ, Istanbul, Bursa, Pendik, Bornova, Kocaeli, Konya
2023-06-30
Active, closed
Regeneron Pharmaceuticals
Phase 2
51
Adana, Yüreğir, Kadıköy, Bornova, Ankara, Istanbul, Izmir
2023-04-21
Recruiting
Regeneron Pharmaceuticals
Phase 3
202
Bornova, Istanbul
2023-03-07
Active, closed
Areteia Therapeutics
Phase 3
600
Adana, Ankara, Antalya, Bornova, Center, Istanbul, Konak, Mersin
2023-01-30
By invitation
Effect of Planned Education on Health Beliefs and Fatalism in Women at High Risk of Breast Cancer
NCT06690320Breast Cancer, Health Behavior, Breast Self-Examination
Ege University
Not applicable
72
Bornova
2023-01-17
Active, closed
Eli Lilly and Company
Phase 3
15,374
Adana, Ankara, Antalya, Aydin, Balçova, Bornova, Denizli, Gaziantep
2022-10-11
Recruiting
Stemline Therapeutics, Inc.
Phase 1/2
73
Adana, Ankara, Bornova, Istanbul
2022-08-31
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Ibrutinib
Loxo Oncology, Inc.
Phase 3
737
Ankara, Balçova, Bornova, Faith, Istanbul, Mamak
2022-07-22
Active, closed
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
NCT05458297Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
DrugsZilovertamab vedotin·Nemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
189
Stanbul, Bornova, Ankara, Edirne, Samsun
2022-07-21
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
154
Altındağ, Bornova, Istanbul
2022-07-13
Active, closed
Celgene
Phase 3
939
Kavaklıdere, Yenimahalle, Pendik, Balçova, Bornova, Samsun, Ankara, Gaziantep
2022-06-23
Active, closed
IO Biotech
Phase 3
407
Adana, Ankara, Antalya, Bornova, Istanbul
2022-05-17
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Balkiraz, Yenimahalle, Pamukkale, Bornova, Trabzon, Gaziantep, Istanbul, Kayseri
2022-04-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
460
Bornova, Adana, Ankara, Istanbul, Izmir
2022-03-24
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
290
Yenimahalle, Bornova, Ankara, Istanbul, Izmir, Samsun
2022-01-14
Active, closed
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)
NCT04770753Non-Transfusion-dependent Alpha-Thalassemia, Non-Transfusion-dependent Beta-Thalassemia
DrugMitapivat
Agios Pharmaceuticals, Inc.
Phase 3
194
Adana, Antalya, Balcalı, Bornova, Fatih, Mersin
2021-12-20
Active, closed
Eli Lilly and Company
Phase 3
152
Bornova, Izmir, Karsiyaka, Adana, Ankara, Antalya, Bursa, Diyarbakır, Edirne
2021-12-20
Recruiting
Merck Sharp & Dohme LLC
Phase 1
830
Bornova, Talas, Ankara
2021-12-17
Active, closed
Merck Sharp & Dohme LLC
Phase 3
643
Sarçam, Fatih, Bornova, Adana, Ankara, Istanbul
2021-12-13
Active, closed
Agios Pharmaceuticals, Inc.
Phase 3
258
Adana, Antalya, Balcalı, Bornova, Fatih, Mersin
2021-11-30
Recruiting
Merck Sharp & Dohme LLC
Phase 2
355
Yüreğir, Bornova, Ankara, Istanbul
2021-08-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Bornova, Izmir, Karsiyaka, Adana, Ankara, Antalya, Istanbul, Malatya
2021-06-18
Active, closed
Savara Inc.
Phase 3
164
Ankara, Istanbul, Bornova
2021-05-19
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Alanya, Altındağ, Ankara, Antalya, Atakum, Bahçelievler, Bornova, Çankaya
2020-12-02
Active, closed
ADC Therapeutics S.A.
Phase 3
440
Çukurambar, Şişli, Bornova, Kurupelit, Ortahisar, Ankara, Kayseri
2020-09-16
Active, closed
Eli Lilly and Company
Phase 3
261
Bornova, Adana, Ankara, Antalya, Diyarbakır, Edirne, Istanbul, Izmir
2020-02-17
Active, closed
Takeda
Phase 3
354
Yüreğir, Kadıköy, Bornova, Karaman, Ankara, Edirne
2020-01-10
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
507
Pendik, Atakum, Balcalı, Bornova, Bursa, Istanbul, Konya, Konyaalti
2018-11-28
Active, closed
Eli Lilly and Company
Phase 3
1,058
Antalya, Bornova, Kocaeli, Mersin
2018-07-18
Active, closed
Gilead Sciences
Phase 3
340
Ankara, Bornova, Çankaya, Maltepe, Topkapı
2017-12-12
Active, closed
Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
NCT02952508Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugCLR 131
Cellectar Biosciences, Inc.
Phase 2
120
Ankara, Bornova, Istanbul
2017-07-26
Active, closed
Eli Lilly and Company
Phase 3
5,637
Istanbul- Fatih, Üsküdar/stanbul, Bornova, Izmir, Karsiyaka, Ankara, Adana, Antalya, Edirne
2017-07-12
Active, closed
Eli Lilly and Company
Phase 3
545
Bornova, Adana, Edirne, Malatya
2015-05-06
Rows per page Showing 1–77 of 77
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/bornova

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 77 of those studies with a site in Bornova.

How many clinical trials are recruiting in Bornova?

32 of the 77 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 41 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bornova), 77 studies
PhaseStudiesRecruitingShare
Phase 3531968.8%
Phase 211414.3%
Phase 2/3435.2%
Phase 1333.9%
Not applicable202.6%
Observational212.6%
Phase 1/2222.6%

Most active sponsors

Lead sponsors with the most studies (Bornova)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC209
Eli Lilly and Company92
Regeneron Pharmaceuticals52
Azafaros B.V.42
Akero Therapeutics, Inc32
Agios Pharmaceuticals, Inc.20
CSL Behring22
Ege University20
Travere Therapeutics, Inc.21
89bio, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.